Below we list the current VCT offers available for investment. Each is accompanied by a brief commentary. The Wealth Club saving includes the discount we offer plus any early bird saving from the VCT.
VCTs are riskier than conventional investments so they're not for everyone. Before you invest you should ensure you have read and understood the product's Application Pack and the Risks and Commitments.
Maven is one of the premier VCT managers. It manages six VCTs alongside its private equity and debt financing activities. Maven has particular strength in the UK regions, with 10 offices around the country.
Mobeus is a private equity house with a strong track record of VCT management. In the past its four VCTs have predominantly invested in MBOs; however since the VCT rule change in 2015 they have built up an experienced growth investing team, led by Trevor Hope (formerly of the ProVen VCTs). Mobeus is good at structuring deals and focuses on mid-stage growth companies; investors will continue to be exposed to the MBO portfolio although this will be replaced over time.
This VCT has always been focused on earlier stage growth-oriented companies. This huge VCT, at £425 million in size, has around 55 companies across a wide range of sectors. The focus is on backing talented entrepreneurs. It has backed some notable winners in the past including Zoopla, SwiftKey and Graze. You can now also invest using an existing ISA.
Albion Capital (formerly Albion Ventures) manages six VCTs; it is one of the longest established VCT managers. The funds have a broad spread of underlying investments in earlier-stage technology, more mature asset backed businesses, renewable energy, healthcare and education, and a strong credible team managing these.
Paul Jourdan, Amati's lead manager is a veteran of investing in smaller companies and launched his first VCT in 2005, which is now called Amati AIM VCT. Dr Jourdan has adapted his approach over the years and now focuses on companies that are cash-generative and growing.
The Calculus VCT invests alongside the long-established Calculus EIS fund, which launched in 1999, offering a lower entry point for investors seeking Calculus’ approach to building a broadly diversified portfolio. In 2017 the VCT merged with Neptune Calculus VCT.
This new share class for the longstanding Downing Four VCT is looking to raise up to £20 million to invest in early-stage healthcare, biotechnology and life sciences businesses. Downing is the overall manager, but will use the skills of specialist healthcare investor BioScience Managers to source and manage deals.
Generalist VCT with a focus on growth businesses, particularly in software and computer services. Now co-invests alongside Draper Esprit which should enhance deal flow and opportunities to invest in larger more established businesses.
Foresight 4 VCT plc has a long history of takeovers, mergers and diverse investment mandates. Look beyond this, however, and the underlying story is a good one, with potentially promising prospects. The Foresight 4 VCT has merged with its smaller sibling, Foresight 3 VCT, and will together raise £50 million, with an over-allotment facility of a further £50 million.
Managed by NVM Private Equity in Newcastle, the three Northern VCTs are among the longest-running Venture Capital Trusts and have built up a strong investor following over the years, gaining a reputation for share offers that quickly sell out. The managers invest in a broad spread of businesses throughout the whole of the UK and have made 11 new VCT-qualifying investments since the rule changes in 2015. Investors will also be exposed to legacy assets consisting mainly of MBO investments.
This is a £30 million fundraise for the Octopus AIM VCT and Octopus AIM VCT 2 (together the Octopus AIM VCTs). Investors will have exposure to a well-established portfolio of maturing and profitable AIM companies plus earlier-stage businesses from newer investments.
Beringea has a solid track record of investing in companies with good potential, particularly in digital media and consumer products, and supporting them until a profitable disposal can be achieved. We believe this is an offer worth considering.
ProVen VCT is a well established VCT with close to £100 million of net assets and 44 companies in the portfolio – ranging from larger, more established companies to younger ones. New investors will benefit from this already diverse portfolio as well as new investments.
Shore Capital is highly experienced in the field of limited-life VCT management. The Puma VCTs aim to return capital after a defined period, investing in companies with assets or contractual revenue streams.
Unicorn is a specialist smaller company fund manager. This VCT has been a consistent long-term performer. The managers look for companies with strong cash flows and potential to pay and grow dividends over time. This is a large, well-diversified VCT and is worthy of consideration.
Calculus Capital has invested in small unquoted companies since 1999, primarily through its EIS fund. The Calculus VCT launched in 2009 and co-invests in many of the same companies. In 2017 the Calculus VCT consolidated its ...
Update (3 November): Baronsmead Venture Trust is now fully subscribed. There is still £8.5 million capacity left in Baronsmead Second Venture Trust. Baronsmead Venture Trust (“BVT”) and Baronsmead Second Venture Trust (“BSVT”) are now open. Together ...
The Northern VCTs are now open. Northern has an extremely loyal base of shareholders. Its previous offer in February of this year sold out in under 48 hours. The three VCTs are now raising up to ...
When you download information from our website or register to receive news and alerts, you become a member of Wealth Club and will receive further information by post and/or email about our products and services. There are no costs or obligations attached to your membership and you can cancel it at any time by contacting us. Your personal data will remain confidential, and will never be passed to any other company, unless required by law.
This website is directed exclusively at, and intended to be used only by, persons in the UK who will be required to self-certify as Sophisticated Investors or High Net Worth Individuals before applying to invest in any of the products featured. It is not directed at any person where (by reason of nationality, residence, domicile or otherwise) the usage of the website is prohibited.
The investment products on this website are not for everyone. They are generally higher risk and require a longer investment term. You may get back less than you invest. It is therefore important that you understand the Risks and Commitments of these products.
We’ve made every effort to ensure the accuracy of the material on this website, but cannot guarantee its accuracy or currency. It reflects our understanding of current product and tax rules, which may change in future. It is for general information only and should not be regarded as constituting an offer or a solicitation to buy or sell any securities, or as investment or tax advice. If you are in any doubt as to the suitability of the products for your circumstances, please seek specialist financial or tax advice.
Wealth Club Limited is not responsible for the content of external third party material featured on our website.